Intramuscular gene transfer of FGF-2 attenuates endothelial dysfunction and inhibits intimal hyperplasia of vein grafts in poor-runoff limbs of rabbit

Tetsuya Shoji, Yoshikazu Yonemitsu, Kimihiro Komori, Mitsugu Tanii, Hiroyuki Itoh, Shihoko Sata, Hiroaki Shimokawa, Mamoru Hasegawa, Katsuo Sueishi, Yoshihiko Maehara

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

We previously demonstrated that sustained disturbance of endothelium-dependent vasorelaxation and poor distal runoff in ischemic limbs were critical factors affecting the neointimal development of autologous vein grafts (VGs). Also, we recently showed the superior therapeutic potential of basic fibroblast growth factor (bFGF/FGF-2) boosted by the recombinant Sendai virus (SeV) for severe limb ischemia compared with that of vascular endothelial growth factor. Here, the effect of FGF-2 on neointimal hyperplasia of VGs was examined in a rabbit model of poor-runoff limbs. Two weeks after initial surgery for the induction of poor-runoff, SeV-expressing human FGF-2 (SeV-hFGF2) or that encoding firefly luciferase (109 plaque-forming units/head) was injected into the thigh and calf muscle. At that time, the femoral vein was implanted in the femoral artery in an end-to-end manner in some groups. FGF-2 gene- transferred limbs demonstrated significantly increased blood flow assessed not only by laser Doppler flow image but also by ultrasonic transit-time flowmeter (USTF). USTF also showed a significant increase in the blood flow ratio of the deep femoral artery to external iliac artery, indicating that collateral flow was significantly restored in the thigh muscles (P < 0.01). Reduction of neointimal hyperplasia was also observed in the VGs treated by SeV-hFGF2; these grafts demonstrated significant restoration of endothelium-dependent vasorelaxation. These findings thus extend the indications of therapeutic angiogenesis using SeV-hFGF2 to include not only limb salvage but also prevention of late graft failure.

Original languageEnglish
Pages (from-to)H173-H182
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume285
Issue number1 54-1
Publication statusPublished - Jul 1 2003

Fingerprint

Tunica Intima
Fibroblast Growth Factor 2
Sendai virus
Hyperplasia
Veins
Extremities
Rabbits
Transplants
Flowmeters
Genes
Femoral Artery
Thigh
Vasodilation
Ultrasonics
Endothelium
Firefly Luciferases
Muscles
Limb Salvage
Femoral Vein
Iliac Artery

All Science Journal Classification (ASJC) codes

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Intramuscular gene transfer of FGF-2 attenuates endothelial dysfunction and inhibits intimal hyperplasia of vein grafts in poor-runoff limbs of rabbit. / Shoji, Tetsuya; Yonemitsu, Yoshikazu; Komori, Kimihiro; Tanii, Mitsugu; Itoh, Hiroyuki; Sata, Shihoko; Shimokawa, Hiroaki; Hasegawa, Mamoru; Sueishi, Katsuo; Maehara, Yoshihiko.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 285, No. 1 54-1, 01.07.2003, p. H173-H182.

Research output: Contribution to journalArticle

Shoji, Tetsuya ; Yonemitsu, Yoshikazu ; Komori, Kimihiro ; Tanii, Mitsugu ; Itoh, Hiroyuki ; Sata, Shihoko ; Shimokawa, Hiroaki ; Hasegawa, Mamoru ; Sueishi, Katsuo ; Maehara, Yoshihiko. / Intramuscular gene transfer of FGF-2 attenuates endothelial dysfunction and inhibits intimal hyperplasia of vein grafts in poor-runoff limbs of rabbit. In: American Journal of Physiology - Heart and Circulatory Physiology. 2003 ; Vol. 285, No. 1 54-1. pp. H173-H182.
@article{f8c79d689bec4056a8a17f21c4514e30,
title = "Intramuscular gene transfer of FGF-2 attenuates endothelial dysfunction and inhibits intimal hyperplasia of vein grafts in poor-runoff limbs of rabbit",
abstract = "We previously demonstrated that sustained disturbance of endothelium-dependent vasorelaxation and poor distal runoff in ischemic limbs were critical factors affecting the neointimal development of autologous vein grafts (VGs). Also, we recently showed the superior therapeutic potential of basic fibroblast growth factor (bFGF/FGF-2) boosted by the recombinant Sendai virus (SeV) for severe limb ischemia compared with that of vascular endothelial growth factor. Here, the effect of FGF-2 on neointimal hyperplasia of VGs was examined in a rabbit model of poor-runoff limbs. Two weeks after initial surgery for the induction of poor-runoff, SeV-expressing human FGF-2 (SeV-hFGF2) or that encoding firefly luciferase (109 plaque-forming units/head) was injected into the thigh and calf muscle. At that time, the femoral vein was implanted in the femoral artery in an end-to-end manner in some groups. FGF-2 gene- transferred limbs demonstrated significantly increased blood flow assessed not only by laser Doppler flow image but also by ultrasonic transit-time flowmeter (USTF). USTF also showed a significant increase in the blood flow ratio of the deep femoral artery to external iliac artery, indicating that collateral flow was significantly restored in the thigh muscles (P < 0.01). Reduction of neointimal hyperplasia was also observed in the VGs treated by SeV-hFGF2; these grafts demonstrated significant restoration of endothelium-dependent vasorelaxation. These findings thus extend the indications of therapeutic angiogenesis using SeV-hFGF2 to include not only limb salvage but also prevention of late graft failure.",
author = "Tetsuya Shoji and Yoshikazu Yonemitsu and Kimihiro Komori and Mitsugu Tanii and Hiroyuki Itoh and Shihoko Sata and Hiroaki Shimokawa and Mamoru Hasegawa and Katsuo Sueishi and Yoshihiko Maehara",
year = "2003",
month = "7",
day = "1",
language = "English",
volume = "285",
pages = "H173--H182",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "1 54-1",

}

TY - JOUR

T1 - Intramuscular gene transfer of FGF-2 attenuates endothelial dysfunction and inhibits intimal hyperplasia of vein grafts in poor-runoff limbs of rabbit

AU - Shoji, Tetsuya

AU - Yonemitsu, Yoshikazu

AU - Komori, Kimihiro

AU - Tanii, Mitsugu

AU - Itoh, Hiroyuki

AU - Sata, Shihoko

AU - Shimokawa, Hiroaki

AU - Hasegawa, Mamoru

AU - Sueishi, Katsuo

AU - Maehara, Yoshihiko

PY - 2003/7/1

Y1 - 2003/7/1

N2 - We previously demonstrated that sustained disturbance of endothelium-dependent vasorelaxation and poor distal runoff in ischemic limbs were critical factors affecting the neointimal development of autologous vein grafts (VGs). Also, we recently showed the superior therapeutic potential of basic fibroblast growth factor (bFGF/FGF-2) boosted by the recombinant Sendai virus (SeV) for severe limb ischemia compared with that of vascular endothelial growth factor. Here, the effect of FGF-2 on neointimal hyperplasia of VGs was examined in a rabbit model of poor-runoff limbs. Two weeks after initial surgery for the induction of poor-runoff, SeV-expressing human FGF-2 (SeV-hFGF2) or that encoding firefly luciferase (109 plaque-forming units/head) was injected into the thigh and calf muscle. At that time, the femoral vein was implanted in the femoral artery in an end-to-end manner in some groups. FGF-2 gene- transferred limbs demonstrated significantly increased blood flow assessed not only by laser Doppler flow image but also by ultrasonic transit-time flowmeter (USTF). USTF also showed a significant increase in the blood flow ratio of the deep femoral artery to external iliac artery, indicating that collateral flow was significantly restored in the thigh muscles (P < 0.01). Reduction of neointimal hyperplasia was also observed in the VGs treated by SeV-hFGF2; these grafts demonstrated significant restoration of endothelium-dependent vasorelaxation. These findings thus extend the indications of therapeutic angiogenesis using SeV-hFGF2 to include not only limb salvage but also prevention of late graft failure.

AB - We previously demonstrated that sustained disturbance of endothelium-dependent vasorelaxation and poor distal runoff in ischemic limbs were critical factors affecting the neointimal development of autologous vein grafts (VGs). Also, we recently showed the superior therapeutic potential of basic fibroblast growth factor (bFGF/FGF-2) boosted by the recombinant Sendai virus (SeV) for severe limb ischemia compared with that of vascular endothelial growth factor. Here, the effect of FGF-2 on neointimal hyperplasia of VGs was examined in a rabbit model of poor-runoff limbs. Two weeks after initial surgery for the induction of poor-runoff, SeV-expressing human FGF-2 (SeV-hFGF2) or that encoding firefly luciferase (109 plaque-forming units/head) was injected into the thigh and calf muscle. At that time, the femoral vein was implanted in the femoral artery in an end-to-end manner in some groups. FGF-2 gene- transferred limbs demonstrated significantly increased blood flow assessed not only by laser Doppler flow image but also by ultrasonic transit-time flowmeter (USTF). USTF also showed a significant increase in the blood flow ratio of the deep femoral artery to external iliac artery, indicating that collateral flow was significantly restored in the thigh muscles (P < 0.01). Reduction of neointimal hyperplasia was also observed in the VGs treated by SeV-hFGF2; these grafts demonstrated significant restoration of endothelium-dependent vasorelaxation. These findings thus extend the indications of therapeutic angiogenesis using SeV-hFGF2 to include not only limb salvage but also prevention of late graft failure.

UR - http://www.scopus.com/inward/record.url?scp=0037662951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037662951&partnerID=8YFLogxK

M3 - Article

C2 - 12623787

AN - SCOPUS:0037662951

VL - 285

SP - H173-H182

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 1 54-1

ER -